Biotoxtech Co., Ltd. (KOSDAQ:086040)
2,910.00
+30.00 (1.04%)
At close: Apr 1, 2025, 3:30 PM KST
Biotoxtech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -6,427 | -4,878 | 2,725 | 7,114 | 2,614 | Upgrade
|
Depreciation & Amortization | 4,098 | 3,679 | 1,945 | 1,672 | 1,631 | Upgrade
|
Loss (Gain) From Sale of Assets | 22.86 | 3.75 | -1,969 | 209.58 | 20.1 | Upgrade
|
Loss (Gain) From Sale of Investments | 1,242 | -12.64 | -1,310 | -2,273 | -1,849 | Upgrade
|
Loss (Gain) on Equity Investments | 42.5 | 3.53 | -84.83 | -537.48 | -1,143 | Upgrade
|
Stock-Based Compensation | 290.34 | 323.04 | 132.8 | 69.32 | 393.13 | Upgrade
|
Provision & Write-off of Bad Debts | 1,073 | -220.68 | 1,514 | 101.89 | -5.35 | Upgrade
|
Other Operating Activities | -909.53 | -4,831 | 3,495 | 701.78 | 1,164 | Upgrade
|
Change in Accounts Receivable | -3,546 | 2,216 | -3,062 | -4,865 | 946.69 | Upgrade
|
Change in Inventory | -2,887 | -7,498 | -3,794 | -56.21 | -127.31 | Upgrade
|
Change in Accounts Payable | 131.74 | -241.56 | -32 | 693.57 | 81.42 | Upgrade
|
Change in Other Net Operating Assets | -250.6 | -4,781 | -867.74 | 1,516 | 838.2 | Upgrade
|
Operating Cash Flow | -7,120 | -16,238 | -1,309 | 4,346 | 4,564 | Upgrade
|
Operating Cash Flow Growth | - | - | - | -4.76% | 216.08% | Upgrade
|
Capital Expenditures | -1,977 | -4,452 | -30,676 | -7,619 | -1,366 | Upgrade
|
Sale of Property, Plant & Equipment | 0.53 | 24.35 | 92.32 | 8.02 | 6.87 | Upgrade
|
Cash Acquisitions | - | - | -885.27 | -5,085 | - | Upgrade
|
Divestitures | - | 499.85 | 8,250 | 1,873 | - | Upgrade
|
Sale (Purchase) of Intangibles | -404.15 | -430.36 | -109.6 | -337.58 | -1,174 | Upgrade
|
Investment in Securities | -8,435 | 3,525 | -3,580 | 3,842 | -4,281 | Upgrade
|
Other Investing Activities | -125 | -1,145 | 26.97 | -408.83 | -407.98 | Upgrade
|
Investing Cash Flow | -9,841 | -1,978 | -26,399 | -7,757 | -7,005 | Upgrade
|
Short-Term Debt Issued | 2,000 | 18,100 | 6,040 | - | - | Upgrade
|
Long-Term Debt Issued | 12,000 | 24,500 | 23,000 | 20,084 | 1,825 | Upgrade
|
Total Debt Issued | 14,000 | 42,600 | 29,040 | 20,084 | 1,825 | Upgrade
|
Short-Term Debt Repaid | -3,650 | -8,600 | -5,000 | -52.71 | -1,266 | Upgrade
|
Long-Term Debt Repaid | -8,363 | -1,194 | -2,106 | -964.94 | -939.85 | Upgrade
|
Total Debt Repaid | -12,013 | -9,794 | -7,106 | -1,018 | -2,206 | Upgrade
|
Net Debt Issued (Repaid) | 1,987 | 32,806 | 21,934 | 19,066 | -380.56 | Upgrade
|
Issuance of Common Stock | - | - | - | 393.12 | 250.78 | Upgrade
|
Repurchase of Common Stock | -997.41 | - | - | - | - | Upgrade
|
Other Financing Activities | -226.71 | 216.16 | -5.43 | -180.66 | -11.43 | Upgrade
|
Financing Cash Flow | 762.48 | 33,022 | 21,929 | 19,279 | -141.21 | Upgrade
|
Foreign Exchange Rate Adjustments | 89.32 | -26.16 | -113.35 | -23.05 | -46.93 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | -0 | - | -0 | 0 | Upgrade
|
Net Cash Flow | -16,109 | 14,779 | -5,892 | 15,845 | -2,630 | Upgrade
|
Free Cash Flow | -9,097 | -20,691 | -31,985 | -3,273 | 3,197 | Upgrade
|
Free Cash Flow Growth | - | - | - | - | 221.50% | Upgrade
|
Free Cash Flow Margin | -22.00% | -63.41% | -85.77% | -10.00% | 12.10% | Upgrade
|
Free Cash Flow Per Share | -573.25 | -1340.45 | -2185.30 | -212.62 | 218.97 | Upgrade
|
Cash Interest Paid | 2,016 | 1,851 | 835.52 | 413.22 | 448.49 | Upgrade
|
Cash Income Tax Paid | 138.98 | 1,685 | 214.19 | 14.66 | 0.86 | Upgrade
|
Levered Free Cash Flow | -7,681 | -10,757 | -28,440 | 1,922 | 1,475 | Upgrade
|
Unlevered Free Cash Flow | -4,502 | -8,405 | -27,181 | 2,442 | 1,752 | Upgrade
|
Change in Net Working Capital | 1,122 | 2,101 | -1,027 | -5,763 | -1,932 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.